Article
New Orleans - Determining the relative risk of a cutaneous drug reaction pattern is vital to determining whether the drug(s) in question can be continued currently or rechallenged in the future,
From Pixels to Precision: How Deep Neural Networks Are Enhancing Nail Disease Care
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Polynucleotide Therapy Shows Promise in Scar and Burn Management
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS
Defining Treatment Options for Managing Chronic Atopic Dermatitis: Part 3